2. Home
  3. Video Lectures
  4. Advanced Prostate Cancer

Advanced Prostate Cancer

Advanced Prostate Cancer
The RADICAL PC Project - Jehonathan Pinthus
April 11, 2018
Details
Advanced Prostate Cancer
New Concepts in ADT- Thomas Keane
April 8, 2018
Details
Advanced Prostate Cancer
Neoadjuvant Therapy for Men with High Risk Disease Prior to Prostatectomy - Mary-Ellen Taplin
February 23, 2018
Details
Advanced Prostate Cancer
Discussion on FALCON: Impact of 18F-fluciclovine PET/CT on Clinical Management Choices for Men with Biochemically Recurrent Prostate Cancer
February 15, 2018
Details
Advanced Prostate Cancer
The Past, Present, and Future Approaches to Prostate Biopsies - Baris Turkbey
December 14, 2017
Details
Advanced Prostate Cancer
IRONMAN - A Better Understanding of the Variation in Care and Treatment - Daniel George
December 11, 2017
Details
Advanced Prostate Cancer
Navigating the Adverse Effects of ADT - Neal Shore
December 8, 2017
Details
Advanced Prostate Cancer
Biomarker Development in Advanced Prostate Cancer- Alicia Morgans
November 29, 2017
Details
Advanced Prostate Cancer
Cognitive Function and Hormone Therapy in Advanced Prostate Cancer - Interview with Alicia Morgans
November 13, 2017
Details
Advanced Prostate Cancer
Clinical Genomic Risk Classification - Daniel Spratt
November 20, 2017
Details
Advanced Prostate Cancer
PRONOUNCE Trial: Cardiovascular Outcomes in Prostate Cancer - Susan Slovin
November 14, 2017
Details
Advanced Prostate Cancer
Role of MRI in Men on Active Surveillance - Laurence Klotz
November 14, 2017
Details
Advanced Prostate Cancer
Over-treatment in the Name of Cure: Revisiting Adjuvant Therapy in the Modern Era? - Christopher Sweeney
October 2, 2017
Details
Advanced Prostate Cancer
Navigating the Adverse Effects of ADT: Improving Patient Outcomes - Jehonathan Pinthus and Neal Shore
October 2, 2017
Details
Advanced Prostate Cancer
Is the Evidence Sufficient to Recommend Statins for All Men With Prostate Cancer?- Lorelei Mucci
September 19, 2017
Details
Advanced Prostate Cancer
What the Referring Clinician Needs to Know from Molecular Imaging in Prostate Cancer - Felix Feng
August 16, 2017
Details
Advanced Prostate Cancer
Bones, Hot Flashes and ADT: Using with Chemotherapy and Timing - Thomas Keane
September 1, 2017
Details
Advanced Prostate Cancer
Plasma based Biomarkers in Advanced Prostate Cancer - Gerhardt Attard
July 27, 2017
Details
Advanced Prostate Cancer
APCCC 2017: Interview With Howard Soule
July 12, 2017
Details
Advanced Prostate Cancer
ADT Impact on Cardiovascular Health - Jehonathan Pinthus
June 29, 2017
Details
Advanced Prostate Cancer
Patient-Reported Outcomes (PROs): Personalizing Care in Clinical Practice - Alicia Morgans
June 19, 2017
Details
Advanced Prostate Cancer
Debate: Comparative effectiveness of surgery and radiation: Radiation better? Mack Roach
June 10, 2017
Details
Advanced Prostate Cancer
Using Biomarkers to Determine When Biopsy and When to Repeat the Biopsy- Stephen Williams
April 4, 2017
Details
Advanced Prostate Cancer
Active Surveillance: Protecting Patients From Harm- Laurence Klotz
June 2, 2017
Details
Advanced Prostate Cancer
IRONMAN: An International Registry To Improve Outcomes in Men with Advanced Prostate Cancer- Lorelei Mucci
May 31, 2017
Details
Advanced Prostate Cancer
Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer - Stacy Loeb
May 31, 2017
Details
Advanced Prostate Cancer
Debate: Comparative Effectiveness of Surgery versus Radiation- Laurence Klotz
April 11, 2017
Details
Advanced Prostate Cancer
Update on Mechanisms of Resistance in Castration-Resistant Prostate Cancer- Karim Fizazi
January 31, 2017
Details
Advanced Prostate Cancer
ADT and the Mechanisms of Cardiovascular Disease- E. David Crawford
April 11, 2017
Details
Advanced Prostate Cancer
Mack Roach and Martin Spahn on 'Oligometastases: RP is experimental and should only be done in the context of a prospective clinical trial’ versus 'RP and SBRT to bone disease is a reasonable management strategy for men with oligomets' - STOP 6
February 23, 2017
Details
Advanced Prostate Cancer
Thomas Keane on Vitamin D and Prostate Cancer - STOP 6
February 23, 2017
Details
Advanced Prostate Cancer
Piet Ost on The impact of local treatment of the prostate in patients with newly diagnosed metastatic prostate cancer - STOP 6
February 23, 2017
Details
Advanced Prostate Cancer
Bone Targeted Agents in Metastatic Prostate Cancer: Denosumab, Bisphosphonates and Radium-223 - Noel Clarke
February 14, 2017
Details
Advanced Prostate Cancer
Noel Clarke on Combination Treatment in Hormone-sensitive Prostate Cancer - STOP 6
February 14, 2017
Details
Advanced Prostate Cancer
Noel Clarke on Clinical applications of molecular genetics in prostate cancer - STOP 6
February 14, 2017
Details
Advanced Prostate Cancer
Nicolas Mottet on EAU Guidelines for patients monitoring under treatment - STOP 6
February 13, 2017
Details
Advanced Prostate Cancer
Nicolas Mottet on Managing the primary in elderly/unfit patients - STOP 6
February 13, 2017
Details
Advanced Prostate Cancer
New Concepts in Androgen Deprivation Therapy (ADT) Agonists vs. Antagonists and All the Rest- Tom Keane
February 8, 2017
Details
Advanced Prostate Cancer
Next-generation sequencing of prostate tumors: Use of individualised biomarkers for prognosis and treatment- Martin Spahn
February 1, 2017
Details
Advanced Prostate Cancer
Laurence Klotz on Active surveillance or: Shrinking the gray zone - STOP 6
February 1, 2017
Details
Advanced Prostate Cancer
Karim Fizazi on Sequencing: Combination or individualized treatment - STOP 6
January 31, 2017
Details
Advanced Prostate Cancer
Karim Fizazi v. Bertrand Tombal on 'Hormone-naive metastatic prostate cancer patients should get chemotherapy and ADT as a standard of care' versus 'ADT and AR pathway-targeted agents still have a role in these patients’ - STOP 6
January 27, 2017
Details
Advanced Prostate Cancer
Mark Emberton on Focal therapy for men with intermediate risk prostate cancer and a solitary lesion should be standard of care - STOP 6
January 26, 2017
Details
Advanced Prostate Cancer
Journal Club: Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormones Agonist and an Antagonist
September 27, 2016
Details
Advanced Prostate Cancer
Journal Club Review: Pharmacokinetic Aspects of the Two Novel Oral Drugs - Charles Ryan
September 27, 2016
Details
Advanced Prostate Cancer
Role of the Gonadotrophin-Releasing Hormone Antagonists and Advanced Hormone-Dependent Prostate Cancer - Journal review
September 9, 2016
Details
Advanced Prostate Cancer
Assessment of Cardiovascular Risk with the Use of Androgen Deprivation Therapy for Prostate Cancer - Matthew Roe
September 2, 2016
Details
Advanced Prostate Cancer
Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer
September 14, 2016
Details
Advanced Prostate Cancer
The understanding of personalized androgen deprivation therapy
April 29, 2016
Details
Advanced Prostate Cancer
Outpatient Urologic Oncology: Primer for the Advanced Practice Provider - Anne Calvaresi
July 27, 2015
Details
Advanced Prostate Cancer
E. David Crawford and Neal Shore - A Conversation on the Role of Chemotherapy in mHSPCa Patients
July 20, 2015
Details
Advanced Prostate Cancer
A Review of Recent Data on Disease-related Outcomes Comparing Agonists and Antagonists for ADT - Thomas Keane
April 1, 2015
Details
Advanced Prostate Cancer
Prospective Evaluation of Testosterone Fluctuations During a Transition from Degarelix to Leuprolide - Jack Zuckerman
February 11, 2015
Details
Advanced Prostate Cancer
Pooled Data from Trials Comparing Degarelix with LHRH Agonist in Men with Advanced Prostate Cancer - Laurence Klotz
April 5, 2016
Details
Advanced Prostate Cancer
Androgen Deprivation Therapy for Prostate Cancer: Comparing Degarelix to Leuprolide - Thomas Keane
January 14, 2015
Details
Advanced Prostate Cancer
Early Treatment for Advanced Prostate Cancer - Judd Moul
January 14, 2016
Details
Advanced Prostate Cancer
Experience with Degarelix in the Treatment of Prostate Cancer - Neal Shore
May 5, 2016
Details